Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

Trial Profile

A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients

Recruiting
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2018

At a glance

  • Drugs Paclitaxel (Primary)
  • Indications Advanced breast cancer
  • Focus Pharmacokinetics
  • Sponsors Athenex
  • Most Recent Events

    • 22 Oct 2018 Results presented in an Athenex media release.
    • 22 Oct 2018 According to an Athenex media release, data from was presented at the European Society for Medical Oncology (ESMO) Congress 2018.
    • 16 Oct 2018 According to an Athenex release, data will be presented at a Poster Discussion in the European Society for Medical Oncology (ESMO) Congress in Munich, Germany.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top